Edoardo Mannucci

Top papers

• Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

  Giovanni Corona, Giulia Rastrelli, Matteo Monami, et al.·2011·European Journal of Endocrinology
  ↗ 433
• Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis

  Giovanni Corona, Giulia Rastrelli, Matteo Monami, et al.·2013·European Journal of Endocrinology
  ↗ 404OA
• Testosterone and Metabolic Syndrome: A Meta-Analysis Study

  Giovanni Corona, Matteo Monami, Giulia Rastrelli, et al.·2010·The Journal of Sexual Medicine
  ↗ 390
• Type 2 diabetes mellitus and testosterone: a meta-analysis study

  Giovanni Corona, Matteo Monami, Giulia Rastrelli, et al.·2010·International Journal of Andrology
  ↗ 369OA
• Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials

  Caterina Lamanna, Matteo Monami, Niccolò Marchionni, et al.·2010·Diabetes Obesity and Metabolism
  ↗ 363
• Depression as a Risk Factor for Diabetes

  Francesco Rotella, Edoardo Mannucci·2013·The Journal of Clinical Psychiatry
  ↗ 356
• Effect of Metformin on Glucagon-Like Peptide 1 (GLP-1) and Leptin Levels in Obese Nondiabetic Subjects

  Edoardo Mannucci, Agostino Ognibene, Francesco Cremasco, et al.·2001·Diabetes Care
  ↗ 296OA
• Diagnostic Crossover and Outcome Predictors in Eating Disorders According to DSM-IV and DSM-V Proposed Criteria: A 6-Year Follow-Up Study

  Giovanni Castellini, Carolina Lo Sauro, Edoardo Mannucci, et al.·2011·Psychosomatic Medicine
  ↗ 295
• Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

  Giovanni Corona, Elisa Maseroli, Giulia Rastrelli, et al.·2014·Expert Opinion on Drug Safety
  ↗ 295
• Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

  Paresh Dandona, Chantal Mathieu, Moshe Phillip, et al.·2017·The Lancet Diabetes & Endocrinology
  ↗ 290OA
• Efficacy and safety of sodium glucose co‐transport‐2 inhibitors in type 2 diabetes: a meta‐analysis of randomized clinical trials

  Matteo Monami, Clara Nardini, Edoardo Mannucci·2013·Diabetes Obesity and Metabolism
  ↗ 278OA
• Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures

  Matteo Monami, Ilaria Dicembrini, Alessandro Antenore, et al.·2011·Diabetes Care
  ↗ 267OA